Xiangxue Pharmaceutical Co (SZSE:300147) 3-Year Share Buyback Ratio : 0.00% (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Xiangxue Pharmaceutical Co 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Xiangxue Pharmaceutical Co's current 3-Year Share Buyback Ratio was 0.00%.

The historical rank and industry rank for Xiangxue Pharmaceutical Co's 3-Year Share Buyback Ratio or its related term are showing as below:

During the past 13 years, Xiangxue Pharmaceutical Co's highest 3-Year Share Buyback Ratio was -0.70%. The lowest was -10.90%. And the median was -2.50%.

SZSE:300147's 3-Year Share Buyback Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: -9.7
* Ranked among companies with meaningful 3-Year Share Buyback Ratio only.

Competitive Comparison of Xiangxue Pharmaceutical Co's 3-Year Share Buyback Ratio

For the Biotechnology subindustry, Xiangxue Pharmaceutical Co's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xiangxue Pharmaceutical Co's 3-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xiangxue Pharmaceutical Co's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Xiangxue Pharmaceutical Co's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Xiangxue Pharmaceutical Co 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Xiangxue Pharmaceutical Co (SZSE:300147) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Xiangxue Pharmaceutical Co 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Xiangxue Pharmaceutical Co's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Xiangxue Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiangxue Pharmaceutical Co Ltd (SZSE:300147) » Definitions » 3-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 2 Jinfeng Road , Science City, Guangzhou Economic and Technological Development Z, Guangzhou, CHN, 510663

Website

http://www.xphcn.com

Xiangxue Pharmaceutical Co Ltd is a China-based company engages in the manufacture and distribution of pharmaceutical products. Its diversified healthcare portfolio includes Chinese Herbal Slices, TCM, Life Science, Biomedical Engineering health solutions (food and beverage), healthcare supplements and so on.

Executives

Huang Wei Hua	Supervisors
Tan Wen Hui	Director
Kang Zhi Ying	Executives
Ceng Lun	Executives
Liu Yan	Executives
Lu Feng	Executives
Xu Li	Secretary, Director
Mo Zi Yu	Supervisors
Mai Zhen Jiang	Supervisors
Wang Yong Hui	Directors, executives
He Tao	Executives
Fang Wei Min	Supervisors
Huang Bin	Directors, Directors, and Executives
Wu Jun	Executives
Chen Wen Jin	Executives

Xiangxue Pharmaceutical Co Headlines

No Headlines